Literature DB >> 26189055

Acute rhabdomiolisys in healthy woman.

Tiziana Ciarambino1, Luigi Elio Adinolfi1, Mauro Giordano2.   

Abstract

Our patient is a 42-year-old woman with muscle paralysis, muscle weakness, and fever. On admission, a neurologic examination showed proximal and distal weakness in the leg. Serum creatine phosphokinase and serum myoglobin level were markedly increased (5600 UI/L and 5197 UI/L, respectively). There was no sign of renal failure. Nerve conduction study was negative. Serologic studies for virus titers showed the antibody immunoglobulin M cytomegalovirus. Muscle weakness and its paralysis, fever, and serum creatine kinase level gradually improved after the administration of methylprednisolone intravenous. Cytomegalovirus infection was thought to have played a central role in this case, leading to an acute but reversible peripheral muscle paralysis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26189055     DOI: 10.1016/j.ajem.2015.04.040

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  3 in total

Review 1.  Post-influenza aspergillosis, do not underestimate influenza B.

Authors:  Eric Fl Nulens; Marc Jc Bourgeois; Marijke Bml Reynders
Journal:  Infect Drug Resist       Date:  2017-02-21       Impact factor: 4.003

2.  Clinical implications of serum myoglobin in trauma patients: A retrospective study from a level 1 trauma center.

Authors:  Khalid Ahmed; Husham Abdelrahman; Ayman El-Menyar; Mahmoud Saqr; Ashwin D Silva; Sherif M Alkahky; Jowhara Al Qahtani; Ahammed Mekkodathil; Hassan Al-Thani; Ruben Peralta
Journal:  Int J Crit Illn Inj Sci       Date:  2020-12-29

Review 3.  Acute rhabdomyolysis in hepatitis-associated aplastic anemia patient undergoing allogeneic hematopoietic stem-cell transplantation: case report and literature review.

Authors:  Yuzhu Li; Yilei Hong; Yingying Shen; Qi Liu; Ying Chen; Keding Shao; Yiping Shen; Baodong Ye; Dijiong Wu
Journal:  Eur J Med Res       Date:  2022-03-21       Impact factor: 2.175

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.